miR-1 could decrease the expression of EGFR, PCR1, PCR2, and p-JNK by targeting ANXA2 and Met, thus inhibiting the growth of glioma cells and tumor angiogenesis and reducing the invasiveness of glioma cells (81). Here, ANXA2 is linked to glioma.